Top Markets
#1 Akedo Akedo +73.71%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.71%
#4 Cross Cross +43.52%
#5 Black Phoenix Black Phoenix +33.78%
#6 Cap Cap +25.61%
#7 Velvet Velvet +25.32%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.62%
#9 DoubleZero DoubleZero +12.53%
#10 Humanity Humanity +10.30%
Coin of the day
Akedo Akedo
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rang in aandelen #39101
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aandeelprijs
$0.02243487
Laatst gesynchroniseerd: 2025-06-04
Marktkapitalisatie
$650.09K
Verandering (1 dag)
0.39%
Verandering (1 jaar)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Categorie

Healthcare
Aandelsplitsingen voor Lipidor AB (publ) (LIPI)
Het aandeel Lipidor AB (publ) (symbool: LIPI) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op May 24, 2024.
Eén aandeel LIPI dat vóór May 24, 2024 werd gekocht, staat nu gelijk aan 3.811 aandelen LIPI.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2024-05-24 3811:1000 x3.811 x3.811
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7 x432
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US